These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Montelukast in childhood asthma: what is the evidence for its use? Amlani S, McIvor RA. Expert Rev Respir Med; 2011 Feb; 5(1):17-25. PubMed ID: 21348582 [Abstract] [Full Text] [Related]
16. Montelukast in general pediatric practices. Ngamphaiboon J. J Med Assoc Thai; 2005 Sep 23; 88 Suppl 4():S348-51. PubMed ID: 16623053 [Abstract] [Full Text] [Related]
17. Montelukast in asthmatic patients 6 years-14 years old with an FEV1 > 75%. Becker A, Swern A, Tozzi CA, Yu Q, Reiss T, Knorr B. Curr Med Res Opin; 2004 Oct 23; 20(10):1651-9. PubMed ID: 15462699 [Abstract] [Full Text] [Related]
18. [Importance of leukotriene antagonists in asthma therapy raised]. MMW Fortschr Med; 2008 Mar 27; 150(13):44-5. PubMed ID: 18522358 [No Abstract] [Full Text] [Related]
19. Real-life effectiveness of Singulair (montelukast) in 506 children with mild to moderate asthma. Amirav I. Isr Med Assoc J; 2008 Apr 27; 10(4):287-91. PubMed ID: 18548983 [Abstract] [Full Text] [Related]